Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
α-helical CRF | 360 | None | 0 | Human | Binding | pKd | None | - | 7.55 | -31 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9918582 | |
5-Chloro-N-cyclopropylmethyl-N'-(2,6-dichloro-4-tributylstannanyl-phenyl)-2-methyl-N-propyl-pyrimidine-4,6-diamine | 10161 | None | 0 | Rat | Binding | Ki | = | 3.00 | 8.52 | - | 1 | Binding affinity towards Corticotropin releasing hormone receptor type 1 of rat cerebellum using [125I]Tyr-sauvagine as radioligand. | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/s0960-894x(00)00661-2 | |
antalarmin | 426 | None | 22 | Human | Binding | pKi | = | - | 8.65 | -1 | 2 | Unclassified | Guide to Pharmacology | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://pubmed.ncbi.nlm.nih.gov/8940412 | |
antalarmin | 426 | 125I-Sauvagine | 22 | Human | Binding | pKi | = | 3.10 | 8.51 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | 125I-Astressin + GTP GammaS | 22 | Human | Binding | pKi | = | 8.51 | 8.07 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | 3H-NBI 35965 + GTP GammaS | 22 | Human | Binding | pKi | = | 0.60 | 9.22 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | 125I-Sauvigine + GTP GammaS | 22 | Human | Binding | pKi | = | 1.95 | 8.71 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | 125I-Sauvagine | 22 | Human | Binding | pKi | = | 0.38 | 9.42 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | 125I-Sauvagine | 22 | Human | Binding | pKi | = | 3.10 | 8.51 | -1 | 2 | - | PDSP KiDatabase | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | - | |
antalarmin | 426 | None | 22 | Human | Binding | IC50 | = | 18.62 | 7.73 | -1 | 2 | Displacement of [125I]-Tyr0-sauvagine from human CRFR1 expressed in HEK293 cell membrane homogenates after 120 mins by gamma counting method | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1016/j.ejmech.2017.07.016 | |
antalarmin | 426 | None | 22 | Human | Binding | IC50 | = | 18.62 | 7.73 | -1 | 2 | Displacement of [125I]Tyr0sauvagine from human CRF1 receptor expressed in HEK293 cell membrane after 120 mins by gamma scintillation counting analysis | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1016/j.ejmech.2014.03.040 | |
antalarmin | 426 | None | 22 | Human | Binding | Ki | = | 2.51 | 8.60 | -1 | 2 | Binding affinity for human corticotropin releasing factor receptor 1 expressed in LtK- cells using [125I]sauvagine | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1021/jm049085v | |
antalarmin | 426 | None | 22 | Human | Binding | Ki | = | 3.10 | 8.51 | -1 | 2 | Inhibition of [125I]sauvagine binding to corticotropin releasing factor receptor 1 expressed in LtK- cells | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1021/jm050070m | |
antalarmin | 426 | None | 22 | Human | Binding | Ki | = | 3.10 | 8.51 | -1 | 2 | Binding affinity for corticotropin-releasing factor-1 expressed in leukocyte tyrosine kinase cells | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1021/jm050384+ | |
antalarmin | 426 | None | 22 | Human | Binding | Ki | = | 0.84 | 9.08 | -1 | 2 | Binding affinity to recombinant human Corticotropin releasing factor receptor 1 (hCRF1) expressed in 293EBNA cells | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1021/jm980224g | |
antalarmin | 426 | None | 22 | Rat | Binding | Ki | = | 1.00 | 9.00 | 1 | 2 | Affinity for the Corticotropin releasing factor receptor 1 (CRHR1) was determined in rat brain | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1021/jm034077k | |
antalarmin | 426 | None | 22 | Rat | Binding | Ki | = | 2.50 | 8.60 | 1 | 2 | Compound was tested in vitro for its ability to displace [125 I]Tyr-sauvagine from corticotropin-releasing hormone type 1 receptor in rat cerebellum | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1016/s0960-894x(00)00071-8 | |
astressin | 506 | None | 0 | Human | Binding | pKd | = | - | 8.25 | -3 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9851694 | |
astressin | 506 | None | 0 | Human | Binding | pKd | = | - | 8.25 | -3 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11123370 | |
astressin | 506 | None | 0 | Human | Binding | pKd | = | - | 8.25 | -3 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9918582 |
Showing 1 to 20 of 2,540 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
antalarmin | 426 | None | 22 | Human | Functional | Ki | = | 32.00 | 7.50 | - | 2 | Antagonist activity at human recombinant CRF1 receptor expressed in CHO cells by cAMP assay | ChEMBL | 378.3 | 6 | 0 | 4 | 5.90 | CCCCN(CC)c1nc(C)nc2c1c(C)c(C)n2-c1c(C)cc(C)cc1C | https://dx.doi.org/10.1016/j.bmcl.2011.10.066 | |
astressin | 506 | None | 0 | Human | Functional | pIC50 | = | - | 9.14 | -1 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12361401 | |
astressin 2B | 507 | None | 0 | Human | Functional | pIC50 | > | - | 6.30 | -389 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12361401 | |
CHEMBL10080 | 4302 | None | 0 | Human | Functional | Ki | = | 23.10 | 7.64 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 512.0 | 6 | 1 | 7 | 5.90 | COc1cc(Br)c(Nc2nc(C)nc(-c3ccccc3C(F)(F)F)c2[N+](=O)[O-])c(OC)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10082 | 4306 | None | 0 | Human | Functional | Ki | = | 5.50 | 8.26 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 478.1 | 5 | 0 | 4 | 6.91 | CCN(c1nc(C)nc(-c2ccccc2C(F)(F)F)n1)c1ccc(C(C)C)cc1Br | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10090 | 4325 | None | 0 | Human | Functional | Ki | = | 95.50 | 7.02 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 522.1 | 4 | 0 | 7 | 4.89 | COc1cc(Br)c(-n2c(=O)n(C)c3c(-c4ccccc4C(F)(F)F)nc(C)nc32)c(OC)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10091 | 4327 | None | 0 | Human | Functional | Ki | = | 60.30 | 7.22 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 482.1 | 5 | 2 | 6 | 5.58 | COc1cc(Br)c(Nc2nc(C)nc(-c3ccccc3C(F)(F)F)c2N)c(OC)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10142 | 4404 | None | 0 | Human | Functional | Ki | = | 32.30 | 7.49 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 506.1 | 4 | 0 | 6 | 5.90 | COc1cc(Br)c(-n2c(C)nc3c(-c4ccccc4C(F)(F)F)nc(C)nc32)c(OC)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10154 | 4428 | None | 0 | Human | Functional | Ki | = | 2.00 | 8.70 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 398.1 | 6 | 1 | 4 | 6.03 | CCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1C | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10174 | 4461 | None | 0 | Human | Functional | Ki | = | 33.40 | 7.48 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 502.0 | 3 | 0 | 5 | 7.49 | CSc1nn(-c2c(Cl)cc(Cl)cc2Cl)c2nc(C)nc(-c3ccccc3C(F)(F)F)c12 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10279 | 4609 | None | 0 | Human | Functional | Ki | = | 202.00 | 6.70 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 508.0 | 4 | 1 | 7 | 5.29 | COc1cc(Br)c(-n2c(O)nc3c(-c4ccccc4C(F)(F)F)nc(C)nc32)c(OC)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10315 | 4663 | None | 0 | Human | Functional | Ki | = | 168.00 | 6.78 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 397.2 | 2 | 0 | 5 | 5.13 | Cc1cc(C)c(-n2nnc3c(-c4ccccc4C(F)(F)F)nc(C)nc32)c(C)c1 | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL10504 | 5009 | None | 0 | Human | Functional | Ki | = | 3.70 | 8.43 | - | 1 | Antagonistic activity for Corticotropin releasing factor receptor 1 | ChEMBL | 462.1 | 9 | 0 | 8 | 3.50 | COCCN(CCOC)c1nc(C)nc2c1nnn2-c1ccc(C(C)C)cc1Br | https://dx.doi.org/10.1016/s0960-894x(99)00133-x | |
CHEMBL1077301 | 210950 | None | 0 | Human | Functional | EC50 | = | 9.70 | 8.01 | -8 | 3 | Activity of peptidic agonists on corticotropin releasing factor receptor using agonist-stimulated adenylate cyclase assay | ChEMBL | - | - | - | - | - | CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(N)=O | https://dx.doi.org/10.1021/jm990590f | |
CHEMBL111665 | 9420 | None | 0 | Human | Functional | IC50 | = | 16.00 | 7.80 | - | 1 | Inhibition of Corticotropin releasing factor receptor 1-stimulated cAMP production | ChEMBL | 390.1 | 6 | 0 | 4 | 5.88 | CCCCN(CC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)nn(C)c12 | https://dx.doi.org/10.1016/s0960-894x(03)00622-x | |
CHEMBL111665 | 9420 | None | 0 | Human | Functional | IC50 | = | 16.00 | 7.80 | - | 1 | Compound was tested to inhibit Corticotropin releasing factor receptor 1-stimulated c-AMP production | ChEMBL | 390.1 | 6 | 0 | 4 | 5.88 | CCCCN(CC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)nn(C)c12 | https://dx.doi.org/10.1016/s0960-894x(03)00621-8 | |
CHEMBL112290 | 9545 | None | 0 | Human | Functional | IC50 | = | 15.00 | 7.82 | - | 1 | Inhibition of Corticotropin releasing factor receptor 1-stimulated cAMP production | ChEMBL | 392.1 | 6 | 0 | 5 | 4.72 | CCN(CCOC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)nn(C)c12 | https://dx.doi.org/10.1016/s0960-894x(03)00622-x | |
CHEMBL113097 | 9697 | None | 0 | Human | Functional | IC50 | = | 51.00 | 7.29 | - | 1 | Inhibition of Corticotropin releasing factor receptor 1-stimulated cAMP production | ChEMBL | 386.1 | 6 | 0 | 2 | 7.14 | CCCCN(CC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)cccc12 | https://dx.doi.org/10.1016/s0960-894x(03)00684-x | |
CHEMBL115142 | 10040 | None | 0 | Human | Functional | IC50 | = | 5.00 | 8.30 | - | 1 | Inhibition of Corticotropin releasing factor receptor 1-stimulated cAMP production | ChEMBL | 418.2 | 8 | 0 | 4 | 6.66 | CCCCN(CCCC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)nn(C)c12 | https://dx.doi.org/10.1016/s0960-894x(03)00622-x | |
CHEMBL115142 | 10040 | None | 0 | Human | Functional | IC50 | = | 15.80 | 7.80 | - | 1 | Compound was tested to inhibit Corticotropin releasing factor receptor 1-stimulated c-AMP production | ChEMBL | 418.2 | 8 | 0 | 4 | 6.66 | CCCCN(CCCC)c1cc(C)nc2c(-c3ccc(Cl)cc3Cl)nn(C)c12 | https://dx.doi.org/10.1016/s0960-894x(03)00621-8 |
Showing 1 to 20 of 490 entries